Literature DB >> 31522547

Monitoring chronic headache and medication-overuse headache prevalence in Denmark.

Maria Lurenda Westergaard1, Cathrine Juel Lau2, Karen Allesøe2, Signe Thorup Gjendal2, Rigmor Højland Jensen1.   

Abstract

OBJECTIVES: To study chronic headache and medication-overuse headache (MOH) prevalence; to identify groups with high prevalence of these conditions; and to identify the most frequently used pain medications among respondents with chronic headache.
BACKGROUND: Chronic headache and MOH prevalence in Denmark were last estimated in 2010.
METHODS: In this cross-sectional study, 104,950 individuals aged ≥16 years were randomly sampled for the 2017 Danish Capital Region Health Survey. Responses to questions about headache and use of acute pain medications were linked to demographic registries. MOH was defined as headache ≥15 days/month plus self-report of use of pain medications ≥10 or 15 days/month, in the last three months. Weighted prevalence proportions were calculated.
RESULTS: Among 55,185 respondents, chronic headache prevalence was 3.0% (95% CI: 2.3-3.2) and MOH prevalence was 2.0% (95% CI: 1.8-2.1). Both conditions were more common among females and the middle-aged. Respondents on social welfare or receiving early retirement pensions had the highest prevalences. Among those with chronic headache, 44.7% overused over-the-counter analgesics for headache; paracetamol 41.5%; a combination of different pain relievers 25.3%; ibuprofen 21.9%; opioids 17.0%; combination preparations 14.3%; and triptans 9.1%.
CONCLUSIONS: The highest prevalence of chronic headache and MOH was seen among people with low socioeconomic position. Overuse of paracetamol was most common. Reported opioid use was higher than expected. Groups with high prevalence of MOH should be the focus of public health interventions on rational use of OTC and prescription pain medications.

Entities:  

Keywords:  Chronic headache; epidemiology; medication-overuse headache; pharmacoepidemiology; prevalence

Mesh:

Year:  2019        PMID: 31522547     DOI: 10.1177/0333102419876909

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  6 in total

Review 1.  The Evolution of Medication Overuse Headache: History, Pathophysiology and Clinical Update.

Authors:  Christina Sun-Edelstein; Alan M Rapoport; Wanakorn Rattanawong; Anan Srikiatkhachorn
Journal:  CNS Drugs       Date:  2021-05-17       Impact factor: 5.749

2.  The Prevalence and Level of Awareness of Medication Overuse Headache in Qassim Province, Saudi Arabia: A Cross-Sectional Study.

Authors:  Samer A Almuqairsha; Mohammad I Aldekhail; Abdullah I Aldekhail; Mohammed H Alresaini; Sulaiman S Almarshoud; Salman A Alashqar; Ibrahim Algosair; Haitham H Alresaini
Journal:  Cureus       Date:  2022-08-17

3.  Questionnaire-Based Survey during COVID-19 Vaccination on the Prevalence of Elderly's Migraine, Chronic Daily Headache, and Medication-Overuse Headache in One Japanese City-Itoigawa Hisui Study.

Authors:  Masahito Katsuki; Junko Kawahara; Yasuhiko Matsumori; Chinami Yamagishi; Akihito Koh; Shin Kawamura; Kenta Kashiwagi; Tomohiro Kito; Akio Entani; Toshiko Yamamoto; Miyako Otake; Takashi Ikeda; Fuminori Yamagishi
Journal:  J Clin Med       Date:  2022-08-11       Impact factor: 4.964

4.  Usual care and a self-management support programme versus usual care and a relaxation programme for people living with chronic headache disorders: a randomised controlled trial protocol (CHESS).

Authors:  Shilpa Patel; Felix Achana; Dawn Carnes; Sandra Eldridge; David R Ellard; Frances Griffiths; Kirstie Haywood; Siew Wan Hee; Dipesh Mistry; Hema Mistry; Vivien P Nichols; Stavros Petrou; Tamar Pincus; Rachel Potter; Harbinder Kaur Sandhu; Kimberley Stewart; Stephanie Taylor; Martin Underwood; Manjit Matharu
Journal:  BMJ Open       Date:  2020-04-12       Impact factor: 2.692

5.  Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city-Itoigawa study.

Authors:  Masahito Katsuki; Chinami Yamagishi; Yasuhiko Matsumori; Akihito Koh; Shin Kawamura; Kenta Kashiwagi; Tomohiro Kito; Akio Entani; Toshiko Yamamoto; Takashi Ikeda; Fuminori Yamagishi
Journal:  Neurol Sci       Date:  2022-01-19       Impact factor: 3.830

6.  Measuring health-related quality of life in chronic headache: A comparative evaluation of the Chronic Headache Quality of Life Questionnaire and Headache Impact Test (HIT-6).

Authors:  Kirstie L Haywood; Felix Achana; Vivien Nichols; Gemma Pearce; Barbara Box; Lynne Muldoon; Shilpa Patel; Frances Griffiths; Kimberly Stewart; Martin Underwood; Manjit M Matharu
Journal:  Cephalalgia       Date:  2021-05-04       Impact factor: 6.292

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.